|
ApoE model | [ApoE] | Neurodegeneration | Behavioral phenotype | Gender effects on behavior | References |
|
Apo | NA | Spine density and dendritic length: WT > KO (HC/DG, 12 m) | Water maze: WT > KO (6 m, F and M) | Water maze: M > F (6 m) | [15–21] |
ChAT: WT > KO (HC, 6 m, M) | Anxiety vertical exploratory: KO > WT (6 m, F) | |
|
GFAP-apoE | Matched | Spine length and density: E3 > E4 (HC, 12 m) | Water maze: E3 > E4 (6 m, F) | Water maze: M > F (apoE4 only) | [17, 22–24] |
| Radial arm maze: E3 > E4 (11–14 m, M) | |
|
NSE-apoE | Matched | Synaptophysin: E3 > E4 (HC, 5 m) | Water maze: E3 > E4 (6 m, F) | Water maze: M > F (apoE4 only, 6 m) | |
ChAT activity: E3 > E4 = KO (12 m): | | | [25–27] |
Tau phosphorylation: E4 > E3 (9 m) | | | |
Kainic acid induced neurodegeneration Synaptophysin and MAP-2: E3 > E4 = KO (CX, 5 m) | | | [25] |
|
ApoE-TR | | Spine density and length: E3 > E4 (1, 3 and 12 m) | Water maze/Active Y maze avoidance: E3 > E4 (15 m, F) | Water maze: M > F (6 and 13 m) | |
Dendritic length and node number: E3 > E4 (1 m) | Anxiety elevated platform: E4 > E3 (6–8 m, F) | | |
EPSP interval: E4/E4 > E2/E4 > E3/E3 (1 m) | | | [18, 28–35] |
LTP: E3 > E4 (2–4 m) | | | |
ICH: E4 > E3 (15 m+) | | | |
Vascular amyloid: E4 > E3 (15 m+) | | | |
|